{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:27:26Z","timestamp":1782930446715,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACyT), Mexico","award":["222720"],"award-info":[{"award-number":["222720"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.pharep.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T22:49:42Z","timestamp":1458600582000},"page":"692-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Peroxisome proliferator-activated receptor-\u03b1 stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle"],"prefix":"10.1007","volume":"68","author":[{"given":"Luz","family":"Ibarra-Lara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Del Valle-Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Soria-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Torres-Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"P\u00e9rez-Severiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"S\u00e1nchez-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Ram\u00edrez-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz G.","family":"Cervantes-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo S.","family":"Pastel\u00edn-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor H.","family":"Oidor-Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Zarco-Olvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"S\u00e1nchez-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"9","key":"10.1016\/j.pharep.2016.03.002_bib0160","doi-asserted-by":"crossref","first-page":"e002188","DOI":"10.1161\/JAHA.115.002188","article-title":"Left ventricular structure and risk of cardiovascular events: a framingham heart study cardiac magnetic resonance study","volume":"4","author":"Tsao","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.pharep.2016.03.002_bib0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cardiores.2004.08.013","article-title":"Cardiac oxidative stress in acute and chronic isoproterenol-infused rats","volume":"65","author":"Zhang","year":"2005","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.pharep.2016.03.002_bib0170","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.tips.2005.04.003","article-title":"Nitrosative stress and pharmacological modulation of heart failure","volume":"26","author":"Pacher","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.pharep.2016.03.002_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.14-42","article-title":"A mitochondrial superoxide theory for oxidative stress diseases and aging","volume":"56","author":"Indo","year":"2015","journal-title":"J Clin Biochem Nutr"},{"issue":"3","key":"10.1016\/j.pharep.2016.03.002_bib0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/HJH.0b013e3282f2f0f3","article-title":"Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat","volume":"26","author":"Banks","year":"2008","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.pharep.2016.03.002_bib0185","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1152\/japplphysiol.00182.2010","article-title":"Point chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension","volume":"109","author":"Esler","year":"2010","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.pharep.2016.03.002_bib0190","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/S1462399411001815","article-title":"Angiotensin II and the vascular phenotype in hypertension","volume":"13","author":"Savoia","year":"2011","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"10.1016\/j.pharep.2016.03.002_bib0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20130407","article-title":"Immune mechanisms in hypertension and vascular injury","volume":"126","author":"Schiffrin","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.pharep.2016.03.002_bib0200","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11906-013-0416-6","article-title":"AT(2) receptor and tissue injury: therapeutic implications","volume":"16","author":"Namsolleck","year":"2014","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"10.1016\/j.pharep.2016.03.002_bib0205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/sj.bjp.0703149","article-title":"Peroxisome proliferator-activated receptors in the cardiovascular system","volume":"129","author":"Bishop-Bailey","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"23","key":"10.1016\/j.pharep.2016.03.002_bib0210","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1111\/bph.13029","article-title":"The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges","volume":"172","author":"Cheang","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.pharep.2016.03.002_bib0215","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4330\/wjc.v6.i8.744","article-title":"Peroxisome proliferator-activated receptors for hypertension","volume":"6","author":"Usuda","year":"2014","journal-title":"World J Cardiol"},{"issue":"1-3","key":"10.1016\/j.pharep.2016.03.002_bib0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2009.10.039","article-title":"PPARalpha stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner","volume":"627","author":"Ibarra-Lara","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2016.03.002_bib0225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12272-009-1619-x","article-title":"Synergistic decrease in blood pressure by captopril combined with losartan in spontaneous hypertensive rats","volume":"32","author":"Shin","year":"2009","journal-title":"Arch Pharm Res"},{"issue":"4","key":"10.1016\/j.pharep.2016.03.002_bib0230","first-page":"561","article-title":"Experimental model of severe renal hypertension","volume":"87","author":"Fernandes","year":"1976","journal-title":"J Lab Clin Med"},{"issue":"5","key":"10.1016\/j.pharep.2016.03.002_bib0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1734-1140(10)70347-9","article-title":"Effect of clofibrate on vascular reactivity in a model of high blood pressure secondary to aortic coarctation","volume":"62","author":"Cervantes-Perez","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"15","key":"10.1016\/j.pharep.2016.03.002_bib0240","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/1522-2683(20000901)21:15<3205::AID-ELPS3205>3.0.CO;2-7","article-title":"Detection of neuropeptides using on-capillary copper complexation and capillary electrophoresis with electrochemical detection","volume":"21","author":"Gawron","year":"2000","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.pharep.2016.03.002_bib0245","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/FJC.0b013e31826216ed","article-title":"Clofibrate PPARalpha activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia","volume":"60","author":"Ibarra-Lara","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2016.03.002_bib0250","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/FJC.0000000000000186","article-title":"PPARalpha stimulation modulates myocardial ischemia-induced activation of renin-angiotensin system","volume":"65","author":"Ibarra-Lara","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2016.03.002_bib0255","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0197-0186(90)90025-O","article-title":"Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes","volume":"17","author":"Lebel","year":"1990","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.pharep.2016.03.002_bib0260","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-4347(00)00030-X","article-title":"Free malondialdehyde determination in rat brain tissue by capillary zone electrophoresis: evaluation of two protein removal procedures","volume":"740","author":"Claeson","year":"2000","journal-title":"J Chromatogr B: Biomed Sci Appl"},{"issue":"9","key":"10.1016\/j.pharep.2016.03.002_bib0265","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/10715760500210145","article-title":"Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: the CUPRAC method","volume":"39","author":"Apak","year":"2005","journal-title":"Free Radic Res"},{"key":"10.1016\/j.pharep.2016.03.002_bib0270","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0076-6879(78)53044-9","article-title":"Preparation and assay of superoxide dismutases","volume":"53","author":"Crapo","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharep.2016.03.002_bib0275","first-page":"408","article-title":"Acute myocardial response to stretch: what we (don\u2019t) know","volume":"6","author":"Neves","year":"2015","journal-title":"Front Physiol"},{"issue":"2-3","key":"10.1016\/j.pharep.2016.03.002_bib0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(97)01168-0","article-title":"Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts","volume":"334","author":"Kojda","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2016.03.002_bib0285","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1152\/japplphysiol.00182.2010a","article-title":"Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension","volume":"109","author":"Navar","year":"2010","journal-title":"J Appl Physiol (1985)"},{"issue":"9","key":"10.1016\/j.pharep.2016.03.002_bib0290","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1590\/S0100-879X2002000900001","article-title":"Recent advances in angiotensin II signaling","volume":"35","author":"Touyz","year":"2002","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1016\/j.pharep.2016.03.002_bib0295","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2012.10.014","article-title":"Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats","volume":"67","author":"Jiang","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2016.03.002_bib0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2013.07.007","article-title":"N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress","volume":"76","author":"Mattace Raso","year":"2013","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.pharep.2016.03.002_bib0305","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI200314172","article-title":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension","volume":"111","author":"Landmesser","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharep.2016.03.002_bib0310","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mnfr.201300256","article-title":"Protective effect of a pomace olive oil concentrated in triterpenic acids in alterations related to hypertension in rats: mechanisms involved","volume":"58","author":"Valero-Munoz","year":"2014","journal-title":"Mol Nutr Food Res"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:25Z","timestamp":1752611785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.03.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1734114016000293"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.03.002","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome proliferator-activated receptor-\u03b1 stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}